Assessment of Metabolomic and Proteomic Biomarkers in Detection and Prognosis of Progression of Renal Function in Chronic Kidney Disease

• Esther Nkuipou-Kenfack,

  Affiliations Mosaiques Diagnostics GmbH, Hannover, Germany, Department of Toxicology, Hannover Medical School, Hannover, Germany

  ⨯
• Flore Duranton,

  Affiliation RD Néphrologie, Montpellier, France

  ⨯
• Nathalie Gayrard,

  Affiliation RD Néphrologie, Montpellier, France

  ⨯
• Àngel Argilés,

  Affiliations RD Néphrologie, Montpellier, France, Néphrologie Dialyse St Guilhem, Séte, France, Service de Néphrologie, Dialyse Péritonéale et Transplantation, Montpellier, France

  ⨯
• Ulrika Lundin,

  Affiliation Biocrates life sciences AG, Innsbruck, Austria

  ⨯
• Klaus M. Weinberger,

  Affiliations Biocrates life sciences AG, Innsbruck, Austria, sAnalytiCo Ltd, Belfast, United Kingdom, Department of Biomedical Informatics and Mechatronics, Private University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria

  ⨯
• Mohammed Dakna,

  Affiliation Mosaiques Diagnostics GmbH, Hannover, Germany

  ⨯
• Christian Delles,

  Affiliation BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom

  ⨯
• William Mullen,

  Affiliation BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Holger Husi,

  Affiliation BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Julie Klein,

  Affiliation Mosaiques Diagnostics GmbH, Hannover, Germany

  ⨯
• Thomas Koeck,

  Affiliation Mosaiques Diagnostics GmbH, Hannover, Germany

  ⨯
• Petra Zürbig,

  Affiliation Mosaiques Diagnostics GmbH, Hannover, Germany

  ⨯
• Harald Mischak

  * E-mail: mischak@mosaiques-diagnostics.com

  Affiliations Mosaiques Diagnostics GmbH, Hannover, Germany, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom

  ⨯